Metly, founded in 2024, is pioneering advancements in pharmaceutical strategy with its innovative AI-driven platform. Their slogan, "The intelligence layer for pharma strategy — connecting data, insights, and decisions in one place," encapsulates its mission to seamlessly integrate data into actionable strategies.
The startup leverages artificial intelligence to transform data into strategic insights, offering a real-time overview of market dynamics and opportunities. By synthesizing both internal and external data sources, Metly equips pharmaceutical companies to navigate the complexities of market shifts proactively.
In a recent funding round dated 01 July 2025, Metly secured a €520.00K seed investment from notable investors such as Capital Partners, Dozen Investments, and Ona Capital. The fresh capital infusion is expected to propel the integration of AI capabilities further and enhance their market positioning.
As the demand for data-driven decision-making in healthcare grows, Metly is uniquely positioned to capitalize on this trend, offering substantial growth potential for early investors.
